PERIPHERAL T-CELL LYMPHOMA
Clinical trials for PERIPHERAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered donor cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy made from donor cells (WU-CART-007) for people with CD7-positive blood cancers, including acute myeloid leukemia and T-cell lymphoma that have not responded to standard treatments. The therapy is designed to target and…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Promising lymphoma combo study pulled before starting
Disease control TerminatedThis study was designed to see if adding tazemetostat to standard CHOP chemotherapy could improve outcomes for people with untreated peripheral T cell lymphoma. It was withdrawn before any participants enrolled, so no results are available. The goal was to increase the number of …
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New study aims to find best first treatment for rare blood cancer
Disease control ENROLLING_BY_INVITATIONThis study compares four different chemotherapy combinations as first treatments for peripheral T-cell lymphoma, a rare type of blood cancer. About 114 newly diagnosed patients will receive one of the four regimens to see which works best and has the fewest side effects. The goal…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Blood test breakthrough: new way to monitor rare lymphoma
Knowledge-focused OngoingThis study looks at whether a blood test can find tiny bits of tumor DNA in people with a rare blood cancer called peripheral T-cell lymphoma. About 45 patients with new or returning lymphoma will give blood samples to see if the test works well. The goal is to learn if this meth…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC
-
New blood test could revolutionize lymphoma monitoring
Knowledge-focused OngoingThis study looks at whether a new blood test can find tiny bits of tumor DNA in people with T-cell lymphoma. The goal is to see if this test can help doctors track how well treatment is working and predict if the cancer might come back. About 50 adults with newly diagnosed or ret…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC